Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Microenvironments01:22

Microenvironments

Microorganisms inhabit highly localized spaces known as microenvironments, which are defined by distinct physical and chemical characteristics. These include oxygen concentration, pH, temperature, light availability, and nutrient levels. The conditions within a microenvironment can differ markedly from those in the surrounding area and significantly influence microbial growth, metabolism, and community structure.Microenvironments often display sharp physicochemical gradients over small spatial...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HALP Score in Predicting Post-Liver Transplant Outcomes in Patients with Hepatocellular Carcinoma.

Journal of clinical medicine·2026
Same author

Combined treatment with vitamin K2 and albumin inhibits growth in hepatocellular carcinoma cells by promoting differentiation and apoptosis.

Molecular biology reports·2026
Same author

Transplant Versus Non-Transplant Hepatocellular Carcinoma Patient Characteristics And Survival.

World journal of medical oncology..·2025
Same author

Mean Platelet Volume Is a Poor Prognostic Factor in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology·2025
Same author

Peripheral blood platelet counts identify prognostically diverse clinical phenotypes in hepatocellular carcinoma.

Annals of gastroenterology and the digestive system·2024
Same author

Transplant and non-transplant HCC patients at a single institution.

Hepatology forum·2024
Same journal

Palliative Surgery for Gastric Cancer with Gastric Outlet Obstruction or Anemia due to Tumor Bleeding.

Hepato-gastroenterology·2016
Same journal

A Novel "Artery First" Approach Allowing Safe Resection in Laparoscopic Pancreaticoduodenectomy: The Uncinate Process First Approach.

Hepato-gastroenterology·2016
Same journal

A Phase I Study of S-1 and Gemcitabine with Concurrent Radiotherapy in Patients with Non-Metastatic Advanced Pancreatic Cancer.

Hepato-gastroenterology·2016
Same journal

A Novel Approach for Endoscopic Papillary Balloon Dilation with the Guidewire Left in the Pancreatic Duct to Ensure Pancreatic Stenting.

Hepato-gastroenterology·2016
Same journal

Which Factors are Predictive for Mortality among Hospitalized Patients with Cirrhosis?

Hepato-gastroenterology·2016
Same journal

Hydrodynamics Analysis and CFD Simulation of Portal Venous System by TIPS and LS.

Hepato-gastroenterology·2016
See all related articles

Related Experiment Video

Updated: May 8, 2026

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma
08:25

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma

Published on: April 25, 2025

HCC and its microenvironment.

Brian I Carr, Vito Guerra

    Hepato-Gastroenterology
    |August 13, 2013
    PubMed
    Summary
    This summary is machine-generated.

    Thrombocytopenia in hepatocellular carcinoma (HCC) patients is linked to smaller tumors, poorer liver function, and worse survival. Normal platelet counts in HCC patients correlate with larger tumors and better outcomes.

    More Related Videos

    A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties
    08:40

    A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties

    Published on: August 7, 2020

    Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable Prognosis: A Retrospective Study using QuPath Image Analysis Software
    07:32

    Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable Prognosis: A Retrospective Study using QuPath Image Analysis Software

    Published on: April 12, 2024

    Related Experiment Videos

    Last Updated: May 8, 2026

    Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma
    08:25

    Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma

    Published on: April 25, 2025

    A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties
    08:40

    A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties

    Published on: August 7, 2020

    Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable Prognosis: A Retrospective Study using QuPath Image Analysis Software
    07:32

    Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable Prognosis: A Retrospective Study using QuPath Image Analysis Software

    Published on: April 12, 2024

    Area of Science:

    • Hepatocellular Carcinoma (HCC) Research
    • Hematology
    • Oncology

    Background:

    • Thrombocytopenia is a known surrogate marker for cirrhosis.
    • Phenotypic characteristics of hepatocellular carcinoma (HCC) patients with and without cirrhosis are not well understood.
    • Investigating platelet count in HCC patients can reveal insights into disease pathways.

    Purpose of the Study:

    • To compare the clinical and pathological characteristics of HCC patients with and without thrombocytopenia.
    • To elucidate the relationship between platelet count and HCC phenotypes.
    • To explore potential differences in HCC development pathways based on platelet status.

    Main Methods:

    • A cohort of 668 unresectable HCC patients with biopsy-proven disease was analyzed.
    • Patients were categorized into two groups: those with thrombocytopenia (platelets <125 x 10^9/L) and those with normal platelet counts (125-400 x 10^9/L).
    • Clinical data, including tumor characteristics, liver function tests, and survival, were compared between the groups.

    Main Results:

    • Patients with normal platelet counts exhibited larger tumors and more tumor nodules compared to those with thrombocytopenia.
    • The normal platelet group had better liver function markers (bilirubin, albumin, prothrombin time) but higher levels of GGTP, ALKP, and AFP.
    • Thrombocytopenia was associated with smaller tumors, impaired liver function, and reduced survival.

    Conclusions:

    • Thrombocytopenia in HCC patients is associated with unfavorable prognostic factors, including smaller tumor size, worse liver function, and poorer survival.
    • These findings suggest the significant role of host factors and the liver microenvironment in HCC development.
    • The study supports the hypothesis of at least two distinct pathways for HCC development, potentially influenced by platelet count and underlying liver health.